keyword
https://read.qxmd.com/read/38646913/comparison-of-patient-reported-outcomes-and-clinical-characteristics-among-patients-with-pituitary-macroadenomas-and-giant-adenomas
#1
JOURNAL ARTICLE
Jessa E Miller, Hye Rhyn Chung, Benjamin R Uy, Nikitha Kosaraju, Ryan M Shih, Myungjun Ko, Shannon R Esswein, Arash Abiri, Pooya Khosravi, Nolan Huck, Cecilia H Nguyen, Timothy Hsu, Michael G Kim, Frank P K Hsu, Won Kim, Jivianne K Lee, Jeffrey D Suh, Marvin Bergsneider, Edward C Kuan, Marilene B Wang
Patients with giant adenomas are more likely to have tumor extension into the paranasal sinuses. Compared to macroadenomas, giant adenomas are not associated with worse preoperative SNOT-22 scores.
April 22, 2024: International Forum of Allergy & Rhinology
https://read.qxmd.com/read/38646739/predictors-of-subjective-olfactory-dysfunction-and-sinonasal-quality-of-life-after-endoscopic-transsphenoidal-pituitary-surgery
#2
JOURNAL ARTICLE
Bita R Naimi, Douglas Farquhar, Alexander N Duffy, Emily A Garvey, Patrick Kelly, Chase Kahn, Riyana Doshi, Riya Shah, Mindy R Rabinowitz, Elina Toskala, Marc Rosen, James J Evans, Gurston G Nyquist
BACKGROUND: This is the largest study in North America investigating olfactory outcomes after pituitary surgery to date. OBJECTIVE: Characterize factors associated with subjective olfactory dysfunction (OD) and worsened sinonasal quality-of-life (QOL) after endoscopic TSA. METHODS: Patients undergoing primary TSA for secreting and non-secreting pituitary adenomas between 2017 and 2021 with pre- and post-operative SNOT-22 scores were included...
April 22, 2024: American Journal of Rhinology & Allergy
https://read.qxmd.com/read/38645431/metabolic-and-inflammatory-parameters-in-relation-to-baseline-characterization-and-treatment-outcome-in-patients-with-prolactinoma-insights-from-a-retrospective-cohort-study-at-a-single-tertiary-center
#3
JOURNAL ARTICLE
Susanna Hofbauer, Laura Horka, Samuel Seidenberg, Raffaele Da Mutten, Luca Regli, Carlo Serra, Felix Beuschlein, Zoran Erlic
BACKGROUND: Prolactinomas (PRLs) are prevalent pituitary adenomas associated with metabolic changes and increased cardiovascular morbidity. This study examined clinical, endocrine, metabolic, and inflammatory profiles in PRL patients, aiming to identify potential prognostic markers. METHODS: The study comprised data from 59 PRL patients gathered in a registry at the University Hospital of Zurich. Diagnostic criteria included MRI findings and elevated serum prolactin levels...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38642582/a-challenging-case-of-a-pituitary-macroadenoma-and-toxic-thyroid-adenoma-with-inappropriate-tsh-secretion
#4
JOURNAL ARTICLE
Michaela Despina Carides, Ruchika Mehta, Jaco Louw, Farzahna Mohamed
SUMMARY: Thyroid-stimulating hormone-secreting pituitary adenomas (TSHomas) are rare, accounting for less than 1% of all pituitary adenomas. We present a case of hyperthyroidism secondary to a likely TSHoma and coexisting functional thyroid adenoma. Laboratory errors and familial abnormalities in thyroid function tests were ruled out, and a diagnosis of the toxic thyroid adenoma was confirmed on a thyroid uptake scan. However, the triiodothyronine suppression test was contraindicated due to the patient's cardiovascular disease, and the thyrotropin-releasing hormone stimulation test, measurement of glycoprotein hormone alpha-subunit, and genetic testing were unavailable...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38642577/challenging-diagnosis-of-resistance-to-thyroid-hormone-in-a-patient-with-covid-19-pituitary-microadenoma-and-unusual-response-to-octreotide-long-acting-release-test
#5
JOURNAL ARTICLE
Cristian Petolicchio, Sara Brasili, Stefano Gay, Francesco Cocchiara, Irene Campi, Luca Persani, Lara Vera, Diego Ferone, Federico Gatto
SUMMARY: The resistance to thyroid hormone syndrome (RTHβ) occurs uncommonly and requires a high level of clinical suspicion and specific investigations to reach a precise diagnosis and to avoid unnecessary and potentially harmful therapies. We report a case of a young male patient referred to our unit for SARS-CoV-2 infection and atrial fibrillation with elevated thyroid hormones and non-suppressed thyroid-stimulating hormone (TSH), for which antithyroid therapy was prescribed...
April 1, 2024: Endocrinology, Diabetes & Metabolism Case Reports
https://read.qxmd.com/read/38639770/multi-dynamic-multi-echo-based-mri-for-the-pre-surgical-determination-of-sellar-tumor-consistency-a%C3%A2-quantitative-approach-for-predicting-lesion-resectability
#6
JOURNAL ARTICLE
Mehmet Salih Yildirim, Victor Ulrich Schmidbauer, Alexander Micko, Lisa Lechner, Michael Weber, Julia Furtner, Stefan Wolfsberger, Intesar-Victoria Malla Houech, Anna Cho, Gregor Dovjak, Gregor Kasprian, Daniela Prayer, Wolfgang Marik
PURPOSE: Pre-surgical information about tumor consistency could facilitate neurosurgical planning. This study used multi-dynamic-multi-echo (MDME)-based relaxometry for the quantitative determination of pituitary tumor consistency, with the aim of predicting lesion resectability. METHODS: Seventy-two patients with suspected pituitary adenomas, who underwent preoperative 3 T MRI between January 2020 and January 2022, were included in this prospective study...
April 19, 2024: Clinical Neuroradiology
https://read.qxmd.com/read/38638787/sellar-melanoma-with-lung-metastasis-a-case-report
#7
Lukas Goertz, Christoph Kabbasch, Marco Timmer
We report the case of an 81-year-old patient with no pre-existing medical conditions who presented with a one-week history of progressive horizontal diplopia. Contrast-enhanced brain magnetic resonance imaging showed a heterogeneous sellar mass with the infiltration of the cavernous sinus and sella. Hormone levels were within normal limits. Considering an endocrine inactive pituitary adenoma, the patient underwent transsphenoidal resection. After surgery, the preoperative symptoms completely resolved. Histopathologic examination of the tumor specimen revealed melanoma...
March 2024: Curēus
https://read.qxmd.com/read/38638137/changes-in-acromegaly-comorbidities-treatment-and-outcome-over-three-decades-a-nationwide-cohort-study
#8
JOURNAL ARTICLE
Christian Rosendal, Mai Christiansen Arlien-Søborg, Eigil Husted Nielsen, Marianne Skovsager Andersen, Claus Larsen Feltoft, Marianne Klose, Mikkel Andreassen, Niels Henrik Bruun, Jens Otto Lunde Jørgensen, Jakob Dal
OBJECTIVE: To study the time-dependent changes in disease features of Danish patients with acromegaly, including treatment modalities, biochemical outcome, and comorbidities, with a particular focus on cancer and mortality. METHODS: Pertinent acromegaly-related variables were collected from 739 patients diagnosed since 1990. Data are presented across three decades (1990-1999, 2000-2009, and 2010-2021) based on the year of diagnosis or treatment initiation. RESULTS: Adenoma size and insulin-like growth factor I (IGF-I) levels at diagnosis did not differ significantly between study periods...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38633358/acromegaly-type-1-a-representative-patient
#9
Daniel Cuevas-Ramos, Shlomo Melmed
A 46-year-old woman was troubled by a 3-year history of constant headaches and arthralgias. She was treated with paracetamol with no symptom resolution. An abnormal fasting glucose level prompted endocrine evaluation. On physical examination, she casually mentioned that her wedding ring no longer fit, and she also confirmed an increase in shoe size. There were no characteristic facial features for acromegaly and there was no evidence of acral enlargement. Biochemical evaluation, including insulin-like growth factor type 1 (IGF-1) measurement and oral glucose loading with growth hormone (GH) measurement confirmed excess GH production and a diagnosis of acromegaly...
April 2024: JCEM Case Rep
https://read.qxmd.com/read/38632163/new-insights-into-the-vitamin-d-pth-axis-in-endocrine-driven-metabolic-bone-diseases
#10
REVIEW
Luigi di Filippo, John P Bilezikian, Ernesto Canalis, Umberto Terenzi, Andrea Giustina
BACKGROUND: Endocrine regulation of bone metabolisms is the focus of the "Skeletal Endocrinology" series of meetings. AIMS: To report on the outcome of the discussion on the role of vitamin D/PTH axis in endocrine osteopathies held during the 10th Skeletal Endocrinology Meeting which took place in Stresa (Italy) in March 2023. OUTCOMES: Vitamin D/PTH axis has relevant influence on several outcomes in the general population and in patients affected by endocrinopathies such as hypoparathyroidism and secreting pituitary adenomas...
April 17, 2024: Endocrine
https://read.qxmd.com/read/38628582/double-pituitary-adenomas-report-of-two-cases-and-systematic-review-of-the-literature
#11
Yi Zhang, Xinyue Gong, Jun Pu, Jifang Liu, Zhang Ye, Huijuan Zhu, Lin Lu, Hui Pan, Kan Deng, Yong Yao
OBJECTIVE: Double pituitary adenomas (DPA) are a rare clinical condition, and our knowledge of them is limited. Missing the second lesion leading to incomplete biochemical remission after surgery is an important challenge in DPA management. This study aims to analyze independent prognostic factors in DPA patients and summarize clinical experiences to prevent surgical failure. METHODS: Two cases of DPA patients with Cushing's disease diagnosed and surgically treated at Peking Union Medical College Hospital are reported...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38628542/surgical-treatment-of-pituitary-neuroendocrine-tumors-with-coexisting-intracranial-lesions-a-case-series-and-review-of-the-literature
#12
JOURNAL ARTICLE
Rodolfo Villalobos-Diaz, Ricardo Marian-Magaña, Marcos Vinicius Sangrador-Deitos, Rafael Vazquez-Gregorio, Luis Alberto Rodriguez-Hernandez, German Lopez-Valencia, Jorge Fernando Aragon-Arreola, Jorge Armando Lara-Olivas, Gerardo Yoshiaki Guinto-Nishimura, Aldo Gabriel Eguiluz-Melendez, Juan Luis Gomez-Amador
BACKGROUND: Pituitary neuroendocrine tumors (PitNETs) are a diverse group of benign neoplasms that account for a significant proportion of intracranial tumors (13%). The coexistence of PitNET with other intracranial lesions, such as meningiomas and intracranial aneurysms, has been constantly reported in the literature; yet, the pathophysiological mechanisms remain unknown, and the appropriate management is controversial. This study aims to describe the clinical characteristics, surgical treatment, and outcomes of patients with PitNET with coexisting intracranial lesions in a single healthcare center...
2024: Surgical Neurology International
https://read.qxmd.com/read/38626285/the-spectrum-of-growth-hormone-excess-in-carney-complex-and-genotype-phenotype-correlations
#13
JOURNAL ARTICLE
Christina Tatsi, Georgia Pitsava, Fabio R Faucz, Meg Keil, Constantine A Stratakis
CONTEXT: Carney complex (CNC) is a familial neoplasia syndrome associated with growth hormone (GH) excess (GHE). OBJECTIVE: To describe the frequency of GHE in a large cohort of patients with CNC, and to identify genotype-phenotype correlations. METHODS: Patients with CNC with at least one biochemical evaluation of GH secretion at our center from 1995-2021 (n=140) were included in the study. Diagnosis of GHE was based on levels of insulin-like growth factor-1 (IGF-1), GH suppression during oral glucose tolerance test (OGTT), GH stimulation after thyrotropin (TRH) administration and overnight GH secretion...
April 13, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38625822/gh-and-prolactin-co-secreting-adenomas-it-is-time-for-a-definition
#14
EDITORIAL
Luiz Eduardo Wildemberg, Mônica R Gadelha
No abstract text is available yet for this article.
April 16, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38622616/headache-alleviation-with-nasal-irrigation-following-endoscopic-endonasal-surgery-for-pituitary-adenomas
#15
JOURNAL ARTICLE
Jiayu Gu, Xiaoqun Chen, Xiaoman Cheng, Yunzhi Zou, Zekun Deng, Depei Li, Zhihuan Zhou, Xiaobing Jiang
BACKGROUND: Headache is a common occurrence after endoscopic endonasal surgery (EES) for pituitary adenomas and significantly impacts the quality of life of patients. This study aims to investigate the effectiveness of nasal irrigation in relieving postoperative headache after EES. METHODS: A retrospective analysis was conducted on a cohort of 101 patients (Cohort I) who underwent EES for pituitary adenomas to explore the risk factors associated with postoperative headache...
April 15, 2024: BMC Endocrine Disorders
https://read.qxmd.com/read/38616022/suprasellar-multiple-neurocysticercal-ncc-cyst-presenting-with-visual-loss
#16
Subhas Konar, Mohammed Nadeem, Dhaval Shukla
Suprasellar cysticercosis is a rare entity. Only a few cases are reported in the literature.1 Clinically, present with visual loss and endocrinopathy and radiologically mimic craniopharyngioma, cystic pituitary adenoma, and Rathke cleft cyst.2 We present the case of a 34-year-old lady with a history of diminution of vision for two months. On examination, her visual acuity was 6/9 bilaterally, per the Snellen chart. The visual field showed incomplete temporal hemianopia in the right eye and a severely depressed field in the left eye...
April 12, 2024: World Neurosurgery
https://read.qxmd.com/read/38614953/histopathology-of-growth-hormone-secreting-pituitary-tumors-state-of-the-art-and-new-perspectives
#17
REVIEW
Federica Guaraldi, Francesca Ambrosi, Costantino Ricci, Luisa Di Sciascio, Sofia Asioli
Somatotroph (GH) adenomas/PitNETs typically arise from adenohypophysis and are biochemically active, leading to acromegaly and gigantism. More rarely, they present with ectopic origin and do not present overt biochemical or clinical features (silent variants). Histopathological examination should consider the clinical and radiological background, and include multiple steps assessing tumor morphology, pituitary transcription factors (PTFs), hormone secretion, proliferation markers, granulation, and somatostatin receptors (STRs), aimed at depicting as better as possible tumor origin (in case of non-functioning and/or metastatic tumor), and clinical behavior, including response to treatment...
April 2, 2024: Best Practice & Research. Clinical Endocrinology & Metabolism
https://read.qxmd.com/read/38613640/the-effect-of-coping-strategies-on-health-related-quality-of-life-in-acromegaly-patients
#18
JOURNAL ARTICLE
Lisa Schock, Witold X Chmielewski, Sonja Siegel, Mario Detomas, Timo Deutschbein, Sabrina Giese, Jürgen Honegger, Nicole Unger, Ilonka Kreitschmann-Andermahr
PURPOSE: Patients with acromegaly oftentimes exhibit a reduced physical and psychological health-related quality of life (HRQoL). Maladaptive coping styles are associated with poor HRQoL in a number of diseases and patients with pituitary adenomas in general exhibit less effective coping styles than healthy controls. This study aimed to assess coping strategies in acromegaly patients in order to explore leverage points for the improvement of HRQoL. METHODS: In this cross-sectional study, we administered self-report surveys for coping strategies and HRQoL (Short Form SF-36, Freiburg questionnaire on coping with illness, FKV-LIS) in patients with acromegaly...
April 13, 2024: Endocrine
https://read.qxmd.com/read/38612778/association-between-intracellular-calcium-signaling-and-tumor-recurrence-in-human-non-functioning-pituitary-adenomas
#19
JOURNAL ARTICLE
Yorgui Santiago-Andres, Ana Aquiles, Keiko Taniguchi-Ponciano, Latife Salame, Gerardo Guinto, Moises Mercado, Tatiana Fiordelisio
Clinically non-functioning pituitary adenomas (CNFPAs) are the second most frequent sellar tumor among studies on community-dwelling adults. They are characterized by the absence of hormonal hypersecretion syndrome, and patients present with compressive symptoms, such as a headache and visual field defects. Immunohistochemically, most CNFPAs are of gonadotrope differentiation, with only a few of them being truly null cell adenomas. Although these tumors express receptors for one or more hypothalamic releasing hormones, to what extent this has an impact on the biological and clinical behavior of these neoplasms remains to be defined...
April 3, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38611671/risk-factors-for-isolated-sphenoid-sinusitis-after-endoscopic-endonasal-transsphenoidal-pituitary-surgery
#20
JOURNAL ARTICLE
Yun-Chen Chang, Yu-Ning Tsao, Chi-Cheng Chuang, Cheng-Yu Li, Ta-Jen Lee, Chia-Hsiang Fu, Kuo-Chen Wei, Chi-Che Huang
(1) Background: Transsphenoidal pituitary surgery can be conducted via microscopic or endoscopic approaches, and there has been a growing preference for the latter in recent years. However, the occurrence of rare complications such as postoperative sinusitis remains inadequately documented in the existing literature. (2) Methods: To address this gap, we conducted a comprehensive retrospective analysis of medical records spanning from 2018 to 2023, focusing on patients who underwent transsphenoidal surgery for pituitary neuroendocrine tumors (formerly called pituitary adenoma)...
April 2, 2024: Diagnostics
keyword
keyword
34528
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.